eDevice Receives Tadi Award for the Design of Its New HealthGO Mini Platform

eDeviceHealthGO Mini is a healthcare device directly installed at patients' homes, transmitting vital signs (i.e. blood pressure, weight, oxygen saturation) to medical information systems through the secure eDevice mobile network. HealthGO Mini communicates with medical sensors via Bluetooth or USB. It can be combined with a tablet, offering a powerful user interface for medical applications such as Q&A for disease management.

eDevice has been awarded the renowned Tadi Award for the design of its HealthGO Mini. It also rewards the company's successful strategy that combines technological innovation and investments in product design. This approach allowed eDevice to differentiate itself in the booming market of eHealth and to become the leading provider of Remote Patient Monitoring solutions for healthcare device manufacturers.

Stéphane Schinazi, CEO of eDevice, declares: "The specific needs of chronically-ill patients, the home-and-office environment of our products and the market's regulatory requirements are three key factors that pushed eDevice to place the product design at the core of its strategy. For five years now, we’ve been working closely with the recognized and award-winning French designer Didier Garrigos. Together, we created ergonomic, easy-to-use medical products for patients and elderly people, while keeping a compact and unobtrusive form factor that perfectly blends into the lifestyle of the end-user."

Several innovating products emerged from this collaboration, from the WireX network converter, to the medical platform family HealthGO. More than 200,000 active products are deployed in 150 different countries across the globe, including in the United States where eDevice generates most of its revenue, this year reaching a steady triple digits growth rate.

These incredible results will reflect in new job opportunities within several departments at eDevice, including several new Engineer positions to be filled in 2016.

About eDevice
At the crossroads of telecom and medical fields, eDevice pioneered the Telehealth connectivity space. Since 2002, several market leaders have relied on eDevice to provide solutions that securely and safely transmit medical data between their patients and their systems, with continuous growth and more than 200,000 patients connected with eDevice technology. Based in Bordeaux, France, eDevice's team of experts enables the company to continue steady and profitable growth. Dedicated to quality, eDevice is ISO-9001 and ISO-13485 certified for design, production, marketing of modems and communicating equipment, and provision of global network telecommunication and data transmission services. eDevice develops solutions for M2M and eHealth connectivity, including Telehealth hubs, network converters, cellular modems, and 3G modules. The company also provides secure cellular network access, cellular data management services, as well as medical data storage and front-end application services for Remote Patient Monitoring. Through partnership with technology leaders, the company brings innovative connectivity solutions to medical device manufacturers.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...